Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholesterol and Antioxidant Treatment in SLOS
NCT01773278Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Dec 2008
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DEKAs Plus in Smith-Lemli-Opitz syndrome (SLOS), sponsored by University of Colorado Denver. Started Dec 2008; status: recruiting.
02
Drugs
DEKAs Plus
03
Conditions
Smith-Lemli-Opitz syndrome (SLOS)
Beyond the preview
Go deeper on NCT01773278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773278.